Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Nasdaq: SHPH · Pharmaceutical Preparations · Gaithersburg, MD · filing with the SEC since 2019
Income statement, as filed
In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Report filed | Mar 31, 2026 | Feb 26, 2025 | Mar 21, 2024 | Mar 15, 2023 | · |
| For lenders | |||||
| Net interest income | · | 100,000 | 100,000r | · | · |
| Research and development | 4,054,831 | 3,618,796 | 3,517,093 | 1,047,385r | 1,021,808 |
| General and administrative | 5,672,794 | 1,392,709 | 1,046,854 | 473,714r | 36,500 |
| Total operating expenses | 11,916,824 | 7,696,170 | 5,892,382 | 2,343,826r | 1,742,992 |
| Total costs and expenses | 2,400,000 | 2,100,000 | 100,000 | · | · |
| Operating income | -11,916,824 | -7,696,170 | -5,892,382 | -2,343,826r | -1,742,992 |
| Interest expense | · | · | 2,123,049 | 917,879 | 3,841 |
| Interest and investment income | 1,090 | 38,138 | 79,117 | · | · |
| Total non-operating income (expense) | 195,155 | -1,448,627 | -700,341 | -2,652,243r | 590,858 |
| Income before income taxes | · | · | -6,592,723 | -4,996,069r | -1,152,134 |
| Net income including non-controlling interests | · | -9,539,875 | · | 1,687,508 | · |
| Net income | -11,721,669 | -9,144,797 | -6,592,723 | -4,996,069r | -1,152,134 |
| Preferred dividends | · | · | · | 402,064r | 103,062 |
| Net income to common shareholders | · | · | -6,592,723 | -6,747,137r | -1,255,196 |
| Earnings per share, basic | -7.16 | -79.65r | -88.25rb | -126.00rb | -3.00b |
| Earnings per share, diluted | -7.16 | -82.60r | -88.25rb | -126.00rb | · |
| Weighted average shares, basic | 1,637,926 | 114,807r | 74,651rb | 53,510rb | 372,070b |
| Weighted average shares, diluted | 1,637,926 | 115,493r | 74,651rb | 53,510rb | · |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-25 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Net interest income interest earned less interest paid
us-gaap:InterestIncomeExpenseNetResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesTotal costs and expenses every operating cost, the cost of revenue included
us-gaap:CostsAndExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseDebtInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossPreferred dividends paid to preferred holders before common shareholders
us-gaap:PreferredStockDividendsIncomeStatementImpactNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding